Randomized Controlled Trial of Pingchuan ShunQi Decoction Combined with Western Medicine in the Treatment of Senile Asthmatic Bronchitis
Taihao Wang
Abstract
Taihao Wang
Abstract
[Objective] To observe antiasthmatic ShunQi decoction combined with western medicine treatment of senile asthmatic bronchitis.[ Methods] Using randomized controlled methods,116 patients were numbered according to the order of treatment were randomly divided into two groups.The treatment group and the control group were treated with phlegm,oxygen and other symptomatic treatment,based on the 58 patients of control group were given a simple western medicine treatment,namely,using conventional ceftazidime,levofloxacin treatment,ceftazidime 2g join saline 100mL or levofloxacin intravenous infusion of 100mL,every two weeks for a course of treatment,at the same time orally 2 times daily theophylline sustained-release tablets 0.2g.The treatment group of 58 cases with asthma SHUNQI Decoction(Banxia 9g,Kuandonghua 9g,Baiguo 21,Gancao 3g,Huangcen 4.5g,Mahuang Sangbaipi 9g,Suzi 6g),water will be herbs decoction to 300mL,1 does/day,2 times/day,2 weeks for 1 courses.Observation time in hospital and symptoms of comparison,clinical efficacy,adverse reaction.Continuous 3 courses of treatment,the curative effect.[Results] The treatment group 52 cases were cured,4 cases markedly effective,effective 1 cases,invalid 1 cases,the total efficiency of 98.28%.the control group cured 39 cases,effective in 11 cases,effective 3 cases,invalid 5 cases,the total efficiency of 91.38%.The efficacy of the treatment group than in control group(P 0.05).Clinical symptoms disappeared time and hospitalization time of treatment group was better than that of the control group(P 0.05).[Conclusion] Pingchuan ShunQi decoction combined with western medicine is effective in treating senile asthmatic bronchitis,is worth the clinical promotion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] To observe antiasthmatic ShunQi decoction combined with western medicine treatment of senile asthmatic bronchitis.[ Methods] Using randomized controlled methods,116 patients were numbered according to the order of treatment were randomly divided into two groups.The treatment group and the control group were treated with phlegm,oxygen and other symptomatic treatment,based on the 58 patients of control group were given a simple western medicine treatment,namely,using conventional ceftazidime,levofloxacin treatment,ceftazidime 2g join saline 100mL or levofloxacin intravenous infusion of 100mL,every two weeks for a course of treatment,at the same time orally 2 times daily theophylline sustained-release tablets 0.2g.The treatment group of 58 cases with asthma SHUNQI Decoction(Banxia 9g,Kuandonghua 9g,Baiguo 21,Gancao 3g,Huangcen 4.5g,Mahuang Sangbaipi 9g,Suzi 6g),water will be herbs decoction to 300mL,1 does/day,2 times/day,2 weeks for 1 courses.Observation time in hospital and symptoms of comparison,clinical efficacy,adverse reaction.Continuous 3 courses of treatment,the curative effect.[Results] The treatment group 52 cases were cured,4 cases markedly effective,effective 1 cases,invalid 1 cases,the total efficiency of 98.28%.the control group cured 39 cases,effective in 11 cases,effective 3 cases,invalid 5 cases,the total efficiency of 91.38%.The efficacy of the treatment group than in control group(P 0.05).Clinical symptoms disappeared time and hospitalization time of treatment group was better than that of the control group(P 0.05).[Conclusion] Pingchuan ShunQi decoction combined with western medicine is effective in treating senile asthmatic bronchitis,is worth the clinical promotion.
Key concepts: Medicine, Decoction, Phlegm, Adverse effect, Saline, Randomized controlled trial, Treatment and control groups, Asthma